Clinically, gastric papillary adenocarcinoma typically overexpresses the gastric phenotype mucins MUC5AC and MUC6, which may aid in distinguishing between EGDTA and EGPA. This evidence concerns the gene MUC6 and gastric papillary adenocarcinoma.